It was recently announced that Dr Sarah Teichmann and her group, Teichmann Lab will join the Cambridge Stem Cell Institute (CSCI) and Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID). Sarah joins the University of Cambridge from her role as Head of Cellular Genetics at the Wellcome Sanger Institute, bringing with her a wealth of experience in computational biology. She is also co-founder and principal […]
Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has shown. It is not clear, however, whether these mutated viruses pose an increased risk to patients or are able to evade the vaccine.
On Tuesday 12th September CITIID welcomed a group of fourteen Brazilian high school students from less privileged social groups as part of a visit to the Biomedical Campus. This was not a typical school visit, as these students live and study in rural areas of Brazil, and some belong to indigenous populations or communities first […]
Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. The discovery, published today in Nature Communications, may explain why, even among vulnerable patient groups, some individuals have better responses to vaccines than others.
Leading research experts, donors and key partners came together to celebrate the impact to date of the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), and to showcase the breadth of its current exciting scientific research at a symposium held on Thursday 13th April. CITIID is a flagship Research Institute located within the Jeffrey […]
Researchers from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust examined data from applicants to Specialty Training Posts through Health Education England for the recruitment cycle 2021-22 to look at potential disparities in the success of applicants according to gender, ethnicity and disability. Doctor’s white coat with stethoscope and pens The text […]
A Department of Medicine Research Impact Case from the School of Clinical Medicine REF Submission Cambridge-led trials spanning two decades have tested and led to the use of alternative, less-toxic maintenance treatments for anti-neutrophil cytoplasm antibody associated vasculitis (AAV), a group of rare but aggressive diseases that cause inflammation of blood vessels with the restricted […]
Cambridge journal ‘Disease Models and Mechanisms’ publish interview with Professor Lalita Ramakrishnan to coincide with World TB Day (WHO) Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions […]
A Cambridge institute dedicated to improving cardiovascular and lung health has received a £16 million gift from Canadian entrepreneur and philanthropist Dr Victor Dahdaleh.
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists. Scientists at the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) and Wellcome Sanger Institute showed that following SARS-CoV-2 infection, cells in the lining of the lungs, nasal cells, and immune cells in […]